COX-2, Cell Proliferation and PMA in Head-and-Neck Cancer Cells

E-ISSN： 1875-6115|9|4|203-218

ISSN： 1871-5222

Source： Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol.9, Iss.4, 2009-12, pp. : 203-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A trial of IRX-2 in patients with squamous cell carcinomas of the head and neck

By Hadden J. Verastegui E. Barrera J.L. Kurman M. Meneses A. Zinser J.W. de la Garza J. Hadden E.

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1073-1081

Elsevier

Access to resources Recommend Favorite

Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2

By Meneses A. Verastegui E. Barrera J.L. de la Garza J. Hadden J.W.

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1083-1091

Elsevier

Access to resources Recommend Favorite

Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

Current Molecular Medicine, Vol. 17, Iss. 10, 2018-05 ,pp. : 707-717

Bentham Science Publishers

Access to resources Recommend Favorite

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck

By Lathers D.M.R. Achille N.J. Young M.R.I.

Human Immunology, Vol. 64, Iss. 12, 2003-12 ,pp. : 1160-1166

Elsevier

Access to resources Recommend Favorite

LPS-activated monocytes suppress T-cell immune responses and induce FOXP3 T cells through a COX-2PGE 2 -dependent mechanism

By Bryn Tone Yaqub Sheraz Mahic Milada Henjum Karen Aandahl Einar M. Taskn Kjetil

International Immunology, Vol. 20, Iss. 2, 2008-02 ,pp. : 235-245

Oxford University Press

Access to resources Recommend Favorite